Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05701098 · ClinicalTrials.gov registry record · NA
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
A NA study of Kidney Stone and Nephrolithiasis, sponsored by SonoMotion.
- Active
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 10
- Study locations
NCT05701098: Active NA study of Kidney Stone and Nephrolithiasis, sponsored by SonoMotion.
NCT05701098 is a NA study of Kidney Stone and Nephrolithiasis that is active but no longer recruiting, run by SonoMotion. The registered enrollment target is 116 participants, below the 189-participant average among 28 other Kidney Stone trials with a reported enrollment target (39% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05701098, a NA study of Kidney Stone and Nephrolithiasis, is active but no longer recruiting, sponsored by SonoMotion.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a telehealth visit at 2 weeks, and c) return for an imaging study at approximately 10 weeks post-procedure.
Primary Outcome
Proportion of subjects with a radiographic assessment of the target stone demonstrating either (i) stone free status (zero fragments) or (ii) the presence of only stone fragments small enough to pass spontaneously (≤ 4 mm).
Conditions Studied
Interventions
- DEVICE Break Wave extracorporeal lithotripsy
Study Locations (10)
California
- University of California- San Diego - San Diego
- University of California - San Francisco - San Francisco
- Kaiser Permanente - Santa Clara
Illinois
- Northwestern Medicine - Chicago
Pennsylvania
- Lehigh Valley Health Network - Allentown
Tennessee
- Vanderbilt University - Nashville
Washington
- University of Washington - Seattle
Alberta
- University of Alberta - Edmonton
British Columbia
- University of British Columbia - Vancouver
Ontario
- St. Michael's Hospital, University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2023-10-09 |
| Est. Completion | 2026-01 |
| Phase | NA |
What the registry record for NCT05701098 still lists
NCT05701098 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 189-participant average among 28 other Kidney Stone trials with a reported enrollment target (39% lower).
The record links to 7 conditions, with Kidney Stone appearing as the primary indexed condition, and to 1 intervention - of which Break Wave extracorporeal lithotripsy is the first listed.
NCT05701098 lists 10 locations in 8 states (California, Illinois, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT05701098 about?
NCT05701098 is a clinical study titled "SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)". The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a teleheal...
What is the current status of trial NCT05701098?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2023-10-09. Estimated completion is 2026-01.
What conditions does trial NCT05701098 study?
This clinical trial studies the following conditions: Kidney Stone, Nephrolithiasis, Urolithiasis, Kidney Calculi, Renal Calculi.
What interventions are being tested in trial NCT05701098?
The interventions under investigation include: Break Wave extracorporeal lithotripsy (DEVICE).
Who is sponsoring clinical trial NCT05701098?
This trial is sponsored by SonoMotion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05701098 being conducted?
This trial has 10 study locations across California, Illinois, Pennsylvania, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05701098's enrollment target sits among peer trials
116 9th of 28 higher than 20 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI